Industry Research Reports
Home > Reports > Service & Software > Global Exosome Manufacturing Service Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Exosome Manufacturing Service Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Service & Software
Published Date: 2025-08-05
Pages: 134 Pages
Report ld: 4907792
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global Exosome Manufacturing Service market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Exosome manufacturing service refers to a specialized service offered by companies or research institutions for the production and isolation of exosomes, which are small extracellular vesicles involved in cell-to-cell communication. This service may include exosome isolation, purification, characterization, and customization according to specific research or therapeutic needs.
From a downstream perspective, Laboratory accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Exosome Manufacturing Service leading manufacturers including Guidon (Beijing) Pharmaceutical Technology, Cytoniche, EverZom, Lonza, RoosterBio, SBI, Creative-Biolabs, Esco Aster, EXO Biologics, Eppendorf, etc., dominate supply; the top five capture approximately % of global revenue, with Guidon (Beijing) Pharmaceutical Technology leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Exosome Manufacturing Service market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Guidon (Beijing) Pharmaceutical Technology
- Cytoniche
- EverZom
- Lonza
- RoosterBio
- SBI
- Creative-Biolabs
- Esco Aster
- EXO Biologics
- Eppendorf
- Aethlon Medical
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Human Embryonic Kidney Cell-Derived Exosomes
- Bone Marrow Stem Cell-Derived Exosomes
- Immature Dendritic Cell-Derived Exosomes
- Milk-Derived Exosomes
- Red Blood Cell-Derived Exosomes
- Others
Segment by Application
- Laboratory
- Pharmaceutical Companies
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Exosome Manufacturing Service study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Exosome Manufacturing Service: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Exosome Manufacturing Service Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Human Embryonic Kidney Cell-Derived Exosomes
1.2.3 Bone Marrow Stem Cell-Derived Exosomes
1.2.4 Immature Dendritic Cell-Derived Exosomes
1.2.5 Milk-Derived Exosomes
1.2.6 Red Blood Cell-Derived Exosomes
1.2.7 Others
1.3 Market Segmentation by Application
1.3.1 Global Exosome Manufacturing Service Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Laboratory
1.3.3 Pharmaceutical Companies
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Exosome Manufacturing Service Revenue Estimates and Forecasts 2020-2031
2.2 Global Exosome Manufacturing Service Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Exosome Manufacturing Service Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Exosome Manufacturing Service Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Human Embryonic Kidney Cell-Derived Exosomes Market Size by Players
3.3.2 Bone Marrow Stem Cell-Derived Exosomes Market Size by Players
3.3.3 Immature Dendritic Cell-Derived Exosomes Market Size by Players
3.3.4 Milk-Derived Exosomes Market Size by Players
3.3.5 Red Blood Cell-Derived Exosomes Market Size by Players
3.3.6 Others Market Size by Players
3.4 Global Exosome Manufacturing Service Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Exosome Manufacturing Service Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Exosome Manufacturing Service Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Exosome Manufacturing Service Market Size by Type (2020-2031)
6.4 North America Exosome Manufacturing Service Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Exosome Manufacturing Service Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Exosome Manufacturing Service Market Size by Type (2020-2031)
7.4 Europe Exosome Manufacturing Service Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Exosome Manufacturing Service Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Exosome Manufacturing Service Market Size by Type (2020-2031)
8.4 Asia-Pacific Exosome Manufacturing Service Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Exosome Manufacturing Service Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Exosome Manufacturing Service Market Size by Type (2020-2031)
9.4 Central and South America Exosome Manufacturing Service Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Exosome Manufacturing Service Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Exosome Manufacturing Service Market Size by Type (2020-2031)
10.4 Middle East and Africa Exosome Manufacturing Service Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Exosome Manufacturing Service Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Guidon (Beijing) Pharmaceutical Technology
11.1.1 Guidon (Beijing) Pharmaceutical Technology Corporation Information
11.1.2 Guidon (Beijing) Pharmaceutical Technology Business Overview
11.1.3 Guidon (Beijing) Pharmaceutical Technology Exosome Manufacturing Service Product Features and Attributes
11.1.4 Guidon (Beijing) Pharmaceutical Technology Exosome Manufacturing Service Revenue and Gross Margin (2020-2025)
11.1.5 Guidon (Beijing) Pharmaceutical Technology Exosome Manufacturing Service Revenue by Product in 2024
11.1.6 Guidon (Beijing) Pharmaceutical Technology Exosome Manufacturing Service Revenue by Application in 2024
11.1.7 Guidon (Beijing) Pharmaceutical Technology Exosome Manufacturing Service Revenue by Geographic Area in 2024
11.1.8 Guidon (Beijing) Pharmaceutical Technology Exosome Manufacturing Service SWOT Analysis
11.1.9 Guidon (Beijing) Pharmaceutical Technology Recent Developments
11.2 Cytoniche
11.2.1 Cytoniche Corporation Information
11.2.2 Cytoniche Business Overview
11.2.3 Cytoniche Exosome Manufacturing Service Product Features and Attributes
11.2.4 Cytoniche Exosome Manufacturing Service Revenue and Gross Margin (2020-2025)
11.2.5 Cytoniche Exosome Manufacturing Service Revenue by Product in 2024
11.2.6 Cytoniche Exosome Manufacturing Service Revenue by Application in 2024
11.2.7 Cytoniche Exosome Manufacturing Service Revenue by Geographic Area in 2024
11.2.8 Cytoniche Exosome Manufacturing Service SWOT Analysis
11.2.9 Cytoniche Recent Developments
11.3 EverZom
11.3.1 EverZom Corporation Information
11.3.2 EverZom Business Overview
11.3.3 EverZom Exosome Manufacturing Service Product Features and Attributes
11.3.4 EverZom Exosome Manufacturing Service Revenue and Gross Margin (2020-2025)
11.3.5 EverZom Exosome Manufacturing Service Revenue by Product in 2024
11.3.6 EverZom Exosome Manufacturing Service Revenue by Application in 2024
11.3.7 EverZom Exosome Manufacturing Service Revenue by Geographic Area in 2024
11.3.8 EverZom Exosome Manufacturing Service SWOT Analysis
11.3.9 EverZom Recent Developments
11.4 Lonza
11.4.1 Lonza Corporation Information
11.4.2 Lonza Business Overview
11.4.3 Lonza Exosome Manufacturing Service Product Features and Attributes
11.4.4 Lonza Exosome Manufacturing Service Revenue and Gross Margin (2020-2025)
11.4.5 Lonza Exosome Manufacturing Service Revenue by Product in 2024
11.4.6 Lonza Exosome Manufacturing Service Revenue by Application in 2024
11.4.7 Lonza Exosome Manufacturing Service Revenue by Geographic Area in 2024
11.4.8 Lonza Exosome Manufacturing Service SWOT Analysis
11.4.9 Lonza Recent Developments
11.5 RoosterBio
11.5.1 RoosterBio Corporation Information
11.5.2 RoosterBio Business Overview
11.5.3 RoosterBio Exosome Manufacturing Service Product Features and Attributes
11.5.4 RoosterBio Exosome Manufacturing Service Revenue and Gross Margin (2020-2025)
11.5.5 RoosterBio Exosome Manufacturing Service Revenue by Product in 2024
11.5.6 RoosterBio Exosome Manufacturing Service Revenue by Application in 2024
11.5.7 RoosterBio Exosome Manufacturing Service Revenue by Geographic Area in 2024
11.5.8 RoosterBio Exosome Manufacturing Service SWOT Analysis
11.5.9 RoosterBio Recent Developments
11.6 SBI
11.6.1 SBI Corporation Information
11.6.2 SBI Business Overview
11.6.3 SBI Exosome Manufacturing Service Product Features and Attributes
11.6.4 SBI Exosome Manufacturing Service Revenue and Gross Margin (2020-2025)
11.6.5 SBI Recent Developments
11.7 Creative-Biolabs
11.7.1 Creative-Biolabs Corporation Information
11.7.2 Creative-Biolabs Business Overview
11.7.3 Creative-Biolabs Exosome Manufacturing Service Product Features and Attributes
11.7.4 Creative-Biolabs Exosome Manufacturing Service Revenue and Gross Margin (2020-2025)
11.7.5 Creative-Biolabs Recent Developments
11.8 Esco Aster
11.8.1 Esco Aster Corporation Information
11.8.2 Esco Aster Business Overview
11.8.3 Esco Aster Exosome Manufacturing Service Product Features and Attributes
11.8.4 Esco Aster Exosome Manufacturing Service Revenue and Gross Margin (2020-2025)
11.8.5 Esco Aster Recent Developments
11.9 EXO Biologics
11.9.1 EXO Biologics Corporation Information
11.9.2 EXO Biologics Business Overview
11.9.3 EXO Biologics Exosome Manufacturing Service Product Features and Attributes
11.9.4 EXO Biologics Exosome Manufacturing Service Revenue and Gross Margin (2020-2025)
11.9.5 EXO Biologics Recent Developments
11.10 Eppendorf
11.10.1 Eppendorf Corporation Information
11.10.2 Eppendorf Business Overview
11.10.3 Eppendorf Exosome Manufacturing Service Product Features and Attributes
11.10.4 Eppendorf Exosome Manufacturing Service Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Aethlon Medical
11.11.1 Aethlon Medical Corporation Information
11.11.2 Aethlon Medical Business Overview
11.11.3 Aethlon Medical Exosome Manufacturing Service Product Features and Attributes
11.11.4 Aethlon Medical Exosome Manufacturing Service Revenue and Gross Margin (2020-2025)
11.11.5 Aethlon Medical Recent Developments
12 Exosome Manufacturing ServiceIndustry Chain Analysis
12.1 Exosome Manufacturing Service Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Exosome Manufacturing Service Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Exosome Manufacturing Service Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Exosome Manufacturing Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Exosome Manufacturing Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Exosome Manufacturing Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Exosome Manufacturing Service Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Exosome Manufacturing Service Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Exosome Manufacturing Service Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Exosome Manufacturing Service Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Exosome Manufacturing Service by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Exosome Manufacturing Service as of 2024)
Table 11. Global Exosome Manufacturing Service Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Exosome Manufacturing Service Companies Headquarters
Table 13. Global Exosome Manufacturing Service Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Exosome Manufacturing Service Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Exosome Manufacturing Service Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Exosome Manufacturing Service Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Exosome Manufacturing Service Revenue by Application (2026-2031) & (US$ Million)
Table 21. Exosome Manufacturing Service High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Exosome Manufacturing Service Growth Accelerators and Market Barriers
Table 25. North America Exosome Manufacturing Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Exosome Manufacturing Service Growth Accelerators and Market Barriers
Table 27. Europe Exosome Manufacturing Service Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Exosome Manufacturing Service Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Exosome Manufacturing Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Exosome Manufacturing Service Investment Opportunities and Key Challenges
Table 31. Central and South America Exosome Manufacturing Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Exosome Manufacturing Service Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Exosome Manufacturing Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Guidon (Beijing) Pharmaceutical Technology Corporation Information
Table 35. Guidon (Beijing) Pharmaceutical Technology Description and Major Businesses
Table 36. Guidon (Beijing) Pharmaceutical Technology Product Features and Attributes
Table 37. Guidon (Beijing) Pharmaceutical Technology Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Guidon (Beijing) Pharmaceutical Technology Revenue Proportion by Product in 2024
Table 39. Guidon (Beijing) Pharmaceutical Technology Revenue Proportion by Application in 2024
Table 40. Guidon (Beijing) Pharmaceutical Technology Revenue Proportion by Geographic Area in 2024
Table 41. Guidon (Beijing) Pharmaceutical Technology Exosome Manufacturing Service SWOT Analysis
Table 42. Guidon (Beijing) Pharmaceutical Technology Recent Developments
Table 43. Cytoniche Corporation Information
Table 44. Cytoniche Description and Major Businesses
Table 45. Cytoniche Product Features and Attributes
Table 46. Cytoniche Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Cytoniche Revenue Proportion by Product in 2024
Table 48. Cytoniche Revenue Proportion by Application in 2024
Table 49. Cytoniche Revenue Proportion by Geographic Area in 2024
Table 50. Cytoniche Exosome Manufacturing Service SWOT Analysis
Table 51. Cytoniche Recent Developments
Table 52. EverZom Corporation Information
Table 53. EverZom Description and Major Businesses
Table 54. EverZom Product Features and Attributes
Table 55. EverZom Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. EverZom Revenue Proportion by Product in 2024
Table 57. EverZom Revenue Proportion by Application in 2024
Table 58. EverZom Revenue Proportion by Geographic Area in 2024
Table 59. EverZom Exosome Manufacturing Service SWOT Analysis
Table 60. EverZom Recent Developments
Table 61. Lonza Corporation Information
Table 62. Lonza Description and Major Businesses
Table 63. Lonza Product Features and Attributes
Table 64. Lonza Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Lonza Revenue Proportion by Product in 2024
Table 66. Lonza Revenue Proportion by Application in 2024
Table 67. Lonza Revenue Proportion by Geographic Area in 2024
Table 68. Lonza Exosome Manufacturing Service SWOT Analysis
Table 69. Lonza Recent Developments
Table 70. RoosterBio Corporation Information
Table 71. RoosterBio Description and Major Businesses
Table 72. RoosterBio Product Features and Attributes
Table 73. RoosterBio Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. RoosterBio Revenue Proportion by Product in 2024
Table 75. RoosterBio Revenue Proportion by Application in 2024
Table 76. RoosterBio Revenue Proportion by Geographic Area in 2024
Table 77. RoosterBio Exosome Manufacturing Service SWOT Analysis
Table 78. RoosterBio Recent Developments
Table 79. SBI Corporation Information
Table 80. SBI Description and Major Businesses
Table 81. SBI Product Features and Attributes
Table 82. SBI Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. SBI Recent Developments
Table 84. Creative-Biolabs Corporation Information
Table 85. Creative-Biolabs Description and Major Businesses
Table 86. Creative-Biolabs Product Features and Attributes
Table 87. Creative-Biolabs Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Creative-Biolabs Recent Developments
Table 89. Esco Aster Corporation Information
Table 90. Esco Aster Description and Major Businesses
Table 91. Esco Aster Product Features and Attributes
Table 92. Esco Aster Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Esco Aster Recent Developments
Table 94. EXO Biologics Corporation Information
Table 95. EXO Biologics Description and Major Businesses
Table 96. EXO Biologics Product Features and Attributes
Table 97. EXO Biologics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. EXO Biologics Recent Developments
Table 99. Eppendorf Corporation Information
Table 100. Eppendorf Description and Major Businesses
Table 101. Eppendorf Product Features and Attributes
Table 102. Eppendorf Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Eppendorf Recent Developments
Table 104. Aethlon Medical Corporation Information
Table 105. Aethlon Medical Description and Major Businesses
Table 106. Aethlon Medical Product Features and Attributes
Table 107. Aethlon Medical Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. Aethlon Medical Recent Developments
Table 109. Raw Materials Key Suppliers
Table 110. Distributors List
Table 111. Market Trends and Market Evolution
Table 112. Market Drivers and Opportunities
Table 113. Market Challenges, Risks, and Restraints
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Exosome Manufacturing Service Product Picture
Figure 2. Global Exosome Manufacturing Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Human Embryonic Kidney Cell-Derived Exosomes Product Picture
Figure 4. Bone Marrow Stem Cell-Derived Exosomes Product Picture
Figure 5. Immature Dendritic Cell-Derived Exosomes Product Picture
Figure 6. Milk-Derived Exosomes Product Picture
Figure 7. Red Blood Cell-Derived Exosomes Product Picture
Figure 8. Others Product Picture
Figure 9. Global Exosome Manufacturing Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 10. Laboratory
Figure 11. Pharmaceutical Companies
Figure 12. Others
Figure 13. Exosome Manufacturing Service Report Years Considered
Figure 14. Global Exosome Manufacturing Service Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Exosome Manufacturing Service Revenue (2020-2031) & (US$ Million)
Figure 16. Global Exosome Manufacturing Service Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 17. Global Exosome Manufacturing Service Revenue Market Share by Region (2020-2031)
Figure 18. Global Exosome Manufacturing Service Revenue Market Share Ranking (2024)
Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 20. Human Embryonic Kidney Cell-Derived Exosomes Revenue Market Share by Player in 2024
Figure 21. Bone Marrow Stem Cell-Derived Exosomes Revenue Market Share by Player in 2024
Figure 22. Immature Dendritic Cell-Derived Exosomes Revenue Market Share by Player in 2024
Figure 23. Milk-Derived Exosomes Revenue Market Share by Player in 2024
Figure 24. Red Blood Cell-Derived Exosomes Revenue Market Share by Player in 2024
Figure 25. Others Revenue Market Share by Player in 2024
Figure 26. Global Exosome Manufacturing Service Revenue Market Share by Type (2020-2031)
Figure 27. Global Exosome Manufacturing Service Revenue Market Share by Application (2020-2031)
Figure 28. North America Exosome Manufacturing Service Revenue YoY (2020-2031) & (US$ Million)
Figure 29. North America Top 5 Players Exosome Manufacturing Service Revenue (US$ Million) in 2024
Figure 30. North America Exosome Manufacturing Service Revenue (US$ Million) by Type (2020 - 2031)
Figure 31. North America Exosome Manufacturing Service Revenue (US$ Million) by Application (2020-2031)
Figure 32. US Exosome Manufacturing Service Revenue (2020-2031) & (US$ Million)
Figure 33. Canada Exosome Manufacturing Service Revenue (2020-2031) & (US$ Million)
Figure 34. Mexico Exosome Manufacturing Service Revenue (2020-2031) & (US$ Million)
Figure 35. Europe Exosome Manufacturing Service Revenue YoY (2020-2031) & (US$ Million)
Figure 36. Europe Top 5 Players Exosome Manufacturing Service Revenue (US$ Million) in 2024
Figure 37. Europe Exosome Manufacturing Service Revenue (US$ Million) by Type (2020-2031)
Figure 38. Europe Exosome Manufacturing Service Revenue (US$ Million) by Application (2020-2031)
Figure 39. Germany Exosome Manufacturing Service Revenue (2020-2031) & (US$ Million)
Figure 40. France Exosome Manufacturing Service Revenue (2020-2031) & (US$ Million)
Figure 41. U.K. Exosome Manufacturing Service Revenue (2020-2031) & (US$ Million)
Figure 42. Italy Exosome Manufacturing Service Revenue (2020-2031) & (US$ Million)
Figure 43. Russia Exosome Manufacturing Service Revenue (2020-2031) & (US$ Million)
Figure 44. Asia-Pacific Exosome Manufacturing Service Revenue YoY (2020-2031) & (US$ Million)
Figure 45. Asia-Pacific Top 8 Players Exosome Manufacturing Service Revenue (US$ Million) in 2024
Figure 46. Asia-Pacific Exosome Manufacturing Service Revenue (US$ Million) by Type (2020-2031)
Figure 47. Asia-Pacific Exosome Manufacturing Service Revenue (US$ Million) by Application (2020-2031)
Figure 48. Indonesia Exosome Manufacturing Service Revenue (2020-2031) & (US$ Million)
Figure 49. Japan Exosome Manufacturing Service Revenue (2020-2031) & (US$ Million)
Figure 50. South Korea Exosome Manufacturing Service Revenue (2020-2031) & (US$ Million)
Figure 51. Australia Exosome Manufacturing Service Revenue (2020-2031) & (US$ Million)
Figure 52. India Exosome Manufacturing Service Revenue (2020-2031) & (US$ Million)
Figure 53. Indonesia Exosome Manufacturing Service Revenue (2020-2031) & (US$ Million)
Figure 54. Vietnam Exosome Manufacturing Service Revenue (2020-2031) & (US$ Million)
Figure 55. Malaysia Exosome Manufacturing Service Revenue (2020-2031) & (US$ Million)
Figure 56. Philippines Exosome Manufacturing Service Revenue (2020-2031) & (US$ Million)
Figure 57. Singapore Exosome Manufacturing Service Revenue (2020-2031) & (US$ Million)
Figure 58. Central and South America Exosome Manufacturing Service Revenue YoY (2020-2031) & (US$ Million)
Figure 59. Central and South America Top 5 Players Exosome Manufacturing Service Revenue (US$ Million) in 2024
Figure 60. Central and South America Exosome Manufacturing Service Revenue (US$ Million) by Type (2020-2031)
Figure 61. Central and South America Exosome Manufacturing Service Revenue (US$ Million) by Application (2020-2031)
Figure 62. Brazil Exosome Manufacturing Service Revenue (2020-2025) & (US$ Million)
Figure 63. Argentina Exosome Manufacturing Service Revenue (2020-2025) & (US$ Million)
Figure 64. Middle East and Africa Exosome Manufacturing Service Revenue YoY (2020-2031) & (US$ Million)
Figure 65. Middle East and Africa Top 5 Players Exosome Manufacturing Service Revenue (US$ Million) in 2024
Figure 66. South America Exosome Manufacturing Service Revenue (US$ Million) by Type (2020-2031)
Figure 67. Middle East and Africa Exosome Manufacturing Service Revenue (US$ Million) by Application (2020-2031)
Figure 68. GCC Countries Exosome Manufacturing Service Revenue (2020-2025) & (US$ Million)
Figure 69. Israel Exosome Manufacturing Service Revenue (2020-2025) & (US$ Million)
Figure 70. Egypt Exosome Manufacturing Service Revenue (2020-2025) & (US$ Million)
Figure 71. South Africa Exosome Manufacturing Service Revenue (2020-2025) & (US$ Million)
Figure 72. Exosome Manufacturing Service Industry Chain Mapping
Figure 73. Channels of Distribution (Direct Vs Distribution)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Exosome Manufacturing Service market?
The top companies in the global Exosome Manufacturing Service market are Guidon (Beijing) Pharmaceutical Technology、Cytoniche、EverZom.
Related Reports
Global Exosome Manufacturing Service Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Exosome Manufacturing Service market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-31
Pages: 132
USD 4900.00
(Single User License)
Global Exosome Manufacturing Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Exosome Manufacturing Service market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-31
Pages: 96
USD 4250.00
(Single User License)
Exosome Manufacturing Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Exosome Manufacturing Service was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-19
Pages: 119
USD 3950.00
(Single User License)
Global Exosome Manufacturing Service Market Research Report 2026
The global Exosome Manufacturing Service market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-16
Pages: 120
USD 2900.00
(Single User License)
Global Exosome Manufacturing Service Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Exosome Manufacturing Service market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 96
USD 4250.00
(Single User License)
Exosome Manufacturing Service- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Exosome Manufacturing Service was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-11
Pages: 107
USD 3950.00
(Single User License)
Global Exosome Manufacturing Service Market Research Report 2025
The global market for Exosome Manufacturing Service was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-11
Pages: 81
USD 2900.00
(Single User License)
Global Exosome Manufacturing Service Market Insights, Forecast to 2030
Exosome manufacturing service refers to a specialized service offered by companies or research institutions for the production and isolation of exosomes, which are small extracellular vesicles involved in cell-to-cell communication. This service may include exosome isolation, purification, characterization, and customization according to specific research or therapeutic needs.
Published Date: 2024-05-07
Pages: 135
USD 4900.00
(Single User License)
Global and United States Exosome Manufacturing Service Market Report & Forecast 2024-2030
Exosome manufacturing service refers to a specialized service offered by companies or research institutions for the production and isolation of exosomes, which are small extracellular vesicles involved in cell-to-cell communication. This service may include exosome isolation, purification, characterization, and customization according to specific research or therapeutic needs.
Published Date: 2024-05-07
Pages: 114
USD 4350.00
(Single User License)
Exosome Manufacturing Service- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Exosome manufacturing service refers to a specialized service offered by companies or research institutions for the production and isolation of exosomes, which are small extracellular vesicles involved in cell-to-cell communication. This service may include exosome isolation, purification, characterization, and customization according to specific research or therapeutic needs.
Published Date: 2024-05-07
Pages: 117
USD 3950.00
(Single User License)
Global Exosome Manufacturing Service Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Exosome Manufacturing Service market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-31
Pages: 132
USD 4900.00 (Single User License)Global Exosome Manufacturing Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Exosome Manufacturing Service market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-31
Pages: 96
USD 4250.00 (Single User License)Exosome Manufacturing Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Exosome Manufacturing Service was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-19
Pages: 119
USD 3950.00 (Single User License)Global Exosome Manufacturing Service Market Research Report 2026
The global Exosome Manufacturing Service market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-16
Pages: 120
USD 2900.00 (Single User License)Global Exosome Manufacturing Service Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Exosome Manufacturing Service market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 96
USD 4250.00 (Single User License)Exosome Manufacturing Service- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Exosome Manufacturing Service was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-11
Pages: 107
USD 3950.00 (Single User License)Global Exosome Manufacturing Service Market Research Report 2025
The global market for Exosome Manufacturing Service was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-11
Pages: 81
USD 2900.00 (Single User License)Global Exosome Manufacturing Service Market Insights, Forecast to 2030
Exosome manufacturing service refers to a specialized service offered by companies or research institutions for the production and isolation of exosomes, which are small extracellular vesicles involved in cell-to-cell communication. This service may include exosome isolation, purification, characterization, and customization according to specific research or therapeutic needs.
Published: 2024-05-07
Pages: 135
USD 4900.00 (Single User License)Global and United States Exosome Manufacturing Service Market Report & Forecast 2024-2030
Exosome manufacturing service refers to a specialized service offered by companies or research institutions for the production and isolation of exosomes, which are small extracellular vesicles involved in cell-to-cell communication. This service may include exosome isolation, purification, characterization, and customization according to specific research or therapeutic needs.
Published: 2024-05-07
Pages: 114
USD 4350.00 (Single User License)Exosome Manufacturing Service- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Exosome manufacturing service refers to a specialized service offered by companies or research institutions for the production and isolation of exosomes, which are small extracellular vesicles involved in cell-to-cell communication. This service may include exosome isolation, purification, characterization, and customization according to specific research or therapeutic needs.
Published: 2024-05-07
Pages: 117
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now